Abdominal 0 9 0 9 O
fistula 10 17 10 17 B-chronic_disease

Absolute 0 8 18 26 B-clinical_variable
Neutrophil 9 19 27 37 I-clinical_variable
Count 20 25 38 43 I-clinical_variable
( 26 27 44 45 I-clinical_variable
ANC 27 30 45 48 I-clinical_variable
) 30 31 48 49 I-clinical_variable
≥1,500 32 38 50 56 O
/ 38 39 56 57 I-lower_bound
mm3 39 42 57 60 I-lower_bound
( 43 44 61 62 O
no 44 46 62 64 O
CSF 47 50 65 68 O
support 51 58 69 76 O
) 58 59 76 77 O

Active 0 6 78 84 O
peptic 7 13 85 91 B-chronic_disease
ulcer 14 19 92 97 I-chronic_disease
disease 20 27 98 105 I-chronic_disease

Age 0 3 106 109 B-age
≥18 4 7 110 113 O
years 8 13 114 119 I-lower_bound

Alanine 0 7 120 127 B-clinical_variable
Aminotransferase 8 24 128 144 I-clinical_variable
( 25 26 145 146 I-clinical_variable
ALT 26 29 146 149 I-clinical_variable
) 29 30 149 150 I-clinical_variable
( 31 32 151 152 I-clinical_variable
SGPT 32 36 152 156 I-clinical_variable
) 36 37 156 157 I-clinical_variable
≤3.0 38 42 158 162 O
× 43 44 163 164 I-upper_bound
ULN 45 48 165 168 I-upper_bound

Any 0 3 169 172 O
history 4 11 173 180 O
of 12 14 181 183 O
congenital 15 25 184 194 O
long 26 30 195 199 O
QT 31 33 200 202 B-chronic_disease
syndrome 34 42 203 211 I-chronic_disease

Any 0 3 212 215 O
of 4 6 216 218 O
the 7 10 219 222 O
following 11 20 223 232 O
within 21 27 233 239 O
6 28 29 240 241 B-upper_bound
months 30 36 242 248 I-upper_bound
before 37 43 249 255 O
the 44 47 256 259 O
first 48 53 260 265 O
dose 54 58 266 270 O
of 59 61 271 273 O
study 62 67 274 279 O
treatment 68 77 280 289 B-treatment

Any 0 3 290 293 O
other 4 9 294 299 O
signs 10 15 300 305 O
indicative 16 26 306 316 O
of 27 29 317 319 O
pulmonary 30 39 320 329 B-chronic_disease
hemorrhage 40 50 330 340 I-chronic_disease
within 51 57 341 347 O
3 58 59 348 349 B-upper_bound
months 60 66 350 356 I-upper_bound
before 67 73 357 363 O
the 74 77 364 367 O
first 78 83 368 373 O
dose 84 88 374 378 O
of 89 91 379 381 O
study 92 97 382 387 O
treatment 98 107 388 397 B-treatment

Aspartate 0 9 398 407 B-clinical_variable
Aminotransferase 10 26 408 424 I-clinical_variable
( 27 28 425 426 I-clinical_variable
AST 28 31 426 429 I-clinical_variable
) 31 32 429 430 I-clinical_variable
( 33 34 431 432 I-clinical_variable
SGOT 34 38 432 436 I-clinical_variable
) 38 39 436 437 I-clinical_variable
≤3.0 40 44 438 442 O
× 45 46 443 444 I-upper_bound
ULN 47 50 445 448 I-upper_bound

Bilirubin 0 9 449 458 B-clinical_variable
( 10 11 459 460 O
Gilbert 11 18 460 467 B-chronic_disease
's 18 20 467 469 I-chronic_disease
Disease 21 28 470 477 I-chronic_disease
) 28 29 477 478 O
< 30 31 479 480 O
3.0 32 35 481 484 B-upper_bound
mg 36 38 485 487 I-upper_bound
/ 38 39 487 488 I-upper_bound
dL 39 41 488 490 I-upper_bound

Bilirubin 0 9 491 500 B-clinical_variable
≤ 10 11 501 502 O
1.5 12 15 503 506 B-upper_bound
x 16 17 507 508 I-upper_bound
upper 18 23 509 514 I-upper_bound
limit 24 29 515 520 I-upper_bound
of 30 32 521 523 I-upper_bound
normal 33 39 524 530 I-upper_bound
( 40 41 531 532 I-upper_bound
ULN 41 44 532 535 I-upper_bound
) 44 45 535 536 I-upper_bound

Bowel 0 5 537 542 B-chronic_disease
obstruction 6 17 543 554 I-chronic_disease
or 18 20 555 557 O
gastric 21 28 558 565 B-chronic_disease
outlet 29 35 566 572 I-chronic_disease
obstruction 36 47 573 584 I-chronic_disease

Cardiovascular 0 14 585 599 B-chronic_disease
disorders 15 24 600 609 I-chronic_disease

Clinically 0 10 610 620 O
- 10 11 620 621 O
significant 11 22 621 632 O
gastrointestinal 23 39 633 649 B-chronic_disease
bleeding 40 48 650 658 I-chronic_disease
within 49 55 659 665 O
6 56 57 666 667 B-upper_bound
months 58 64 668 674 I-upper_bound
before 65 71 675 681 I-upper_bound
the 72 75 682 685 O
first 76 81 686 691 O
dose 82 86 692 696 O
of 87 89 697 699 O
study 90 95 700 705 O
treatment 96 105 706 715 B-treatment
b. 106 108 716 718 O
Hemoptysis 108 118 718 728 B-clinical_variable
of 119 121 729 731 O
≥ 122 123 732 733 O
0.5 124 127 734 737 B-lower_bound
teaspoon 128 136 738 746 I-lower_bound
( 137 138 747 748 I-lower_bound
2.5ml 138 143 748 753 I-lower_bound
) 143 144 753 754 I-lower_bound
of 145 147 755 757 O
red 148 151 758 761 O
blood 152 157 762 767 O
within 158 164 768 774 O
3 165 166 775 776 B-upper_bound
months 167 173 777 783 I-upper_bound
before 174 180 784 790 I-upper_bound
the 181 184 791 794 O
first 185 190 795 800 O
dose 191 195 801 805 O
of 196 198 806 808 O
study 199 204 809 814 O
treatment 205 214 815 824 O

Concurrent 0 10 825 835 O
uncompensated 11 24 836 849 O
hypothyroidism 25 39 850 864 B-chronic_disease
or 40 42 865 867 O
thyroid 43 50 868 875 B-chronic_disease
dysfunction 51 62 876 887 I-chronic_disease
within 63 69 888 894 O
7 70 71 895 896 B-upper_bound
days 72 76 897 901 I-upper_bound
before 77 83 902 908 I-upper_bound
the 84 87 909 912 O
first 88 93 913 918 O
dose 94 98 919 923 O
of 99 101 924 926 O
study 102 107 927 932 O
treatment 108 117 933 942 B-treatment

Concurrent 0 10 943 953 O
uncontrolled 11 23 954 966 B-chronic_disease
hypertension 24 36 967 979 I-chronic_disease
defined 37 44 980 987 O
as 45 47 988 990 O
sustained 48 57 991 1000 O
BP 58 60 1001 1003 B-clinical_variable
> 61 62 1004 1005 O
140 63 66 1006 1009 B-lower_bound
mm 67 69 1010 1012 I-lower_bound
Hg 70 72 1013 1015 I-lower_bound
systolic 73 81 1016 1024 O
, 81 82 1024 1025 O
or 83 85 1026 1028 O
> 86 87 1029 1030 O
90 88 90 1031 1033 B-lower_bound
mm 91 93 1034 1036 I-lower_bound
Hg 94 96 1037 1039 I-lower_bound
diastolic 97 106 1040 1049 O
despite 107 114 1050 1057 O
optimal 115 122 1058 1065 B-treatment
antihypertensive 123 139 1066 1082 I-treatment
treatment 140 149 1083 1092 I-treatment
within 150 156 1093 1099 O
7 157 158 1100 1101 B-upper_bound
days 159 163 1102 1106 I-upper_bound
of 164 166 1107 1109 O
the 167 170 1110 1113 O
first 171 176 1114 1119 O
dose 177 181 1120 1124 O
of 182 184 1125 1127 O
study 185 190 1128 1133 O
treatment 191 200 1134 1143 O

Congestive 0 10 1144 1154 B-chronic_disease
heart 11 16 1155 1160 I-chronic_disease
failure 17 24 1161 1168 I-chronic_disease
( 25 26 1169 1170 I-chronic_disease
CHF 26 29 1170 1173 I-chronic_disease
): 29 31 1173 1175 I-chronic_disease
New 32 35 1176 1179 B-clinical_variable
York 36 40 1180 1184 I-clinical_variable
Heart 41 46 1185 1190 I-clinical_variable
Association 47 58 1191 1202 I-clinical_variable
( 59 60 1203 1204 I-clinical_variable
NYHA 60 64 1204 1208 I-clinical_variable
) 64 65 1208 1209 I-clinical_variable
Class 66 71 1210 1215 B-lower_bound
III 72 75 1216 1219 I-lower_bound
( 76 77 1220 1221 O
moderate 77 85 1221 1229 O
) 85 86 1229 1230 O
or 87 89 1231 1233 O
Class 90 95 1234 1239 B-upper_bound
IV 96 98 1240 1242 I-upper_bound
( 99 100 1243 1244 O
severe 100 106 1244 1250 O
) 106 107 1250 1251 O
at 108 110 1252 1254 O
the 111 114 1255 1258 O
time 115 119 1259 1263 O
of 120 122 1264 1266 O
screening 123 132 1267 1276 O

Creatinine 0 10 1277 1287 B-clinical_variable
clearance 11 20 1288 1297 I-clinical_variable
( 21 22 1298 1299 I-clinical_variable
CrCl 22 26 1299 1303 I-clinical_variable
) 26 27 1303 1304 I-clinical_variable
≥40 28 31 1305 1308 O
mL 32 34 1309 1311 I-lower_bound
/ 34 35 1311 1312 I-lower_bound
min 35 38 1312 1315 I-lower_bound

Eastern 0 7 1316 1323 B-clinical_variable
Cooperative 8 19 1324 1335 I-clinical_variable
Oncology 20 28 1336 1344 I-clinical_variable
Group 29 34 1345 1350 I-clinical_variable
( 35 36 1351 1352 I-clinical_variable
ECOG 36 40 1352 1356 I-clinical_variable
) 40 41 1356 1357 I-clinical_variable
performance 42 53 1358 1369 I-clinical_variable
status 54 60 1370 1376 I-clinical_variable
≤2 61 63 1377 1379 O

Female 0 6 1380 1386 B-gender
: 6 7 1386 1387 O
Multiply 8 16 1388 1396 O
above 17 22 1397 1402 O
result 23 29 1403 1409 O
by 30 32 1410 1412 O
0.85 33 37 1413 1417 B-lower_bound
≤ 38 39 1418 1419 O
1.5 40 43 1420 1423 B-upper_bound
x 44 45 1424 1425 I-upper_bound
ULN 46 49 1426 1429 I-upper_bound

First 0 5 1430 1435 O
dose 6 10 1436 1440 O
of 11 13 1441 1443 O
cabozantinib 14 26 1444 1456 B-treatment
occurs 27 33 1457 1463 O
at 34 36 1464 1466 O
least 37 42 1467 1472 O
28 43 45 1473 1475 B-lower_bound
days 46 50 1476 1480 I-lower_bound
after 51 56 1481 1486 O
surgery 57 64 1487 1494 B-treatment
, 64 65 1494 1495 O
and 66 69 1496 1499 O
the 70 73 1500 1503 O
subject 74 81 1504 1511 O
has 82 85 1512 1515 O
recovered 86 95 1516 1525 O
from 96 100 1526 1530 O
the 101 104 1531 1534 O
effects 105 112 1535 1542 O
of 113 115 1543 1545 O
surgery 116 123 1546 1553 O

For 0 3 1554 1557 O
this 4 8 1558 1562 O
reason 9 15 1563 1569 O
women 16 21 1570 1575 B-gender
of 22 24 1576 1578 O
child 25 30 1579 1584 O
- 30 31 1584 1585 O
bearing 31 38 1585 1592 O
potential 39 48 1593 1602 O
and 49 52 1603 1606 O
men 53 56 1607 1610 O
must 57 61 1611 1615 O
agree 62 67 1616 1621 B-contraception_consent
to 68 70 1622 1624 I-contraception_consent
use 71 74 1625 1628 I-contraception_consent
adequate 75 83 1629 1637 I-contraception_consent
contraception 84 97 1638 1651 I-contraception_consent
( 98 99 1652 1653 I-contraception_consent
hormonal 99 107 1653 1661 I-contraception_consent
or 108 110 1662 1664 I-contraception_consent
barrier 111 118 1665 1672 I-contraception_consent
method 119 125 1673 1679 I-contraception_consent
of 126 128 1680 1682 I-contraception_consent
birth 129 134 1683 1688 I-contraception_consent
control 135 142 1689 1696 I-contraception_consent
; 142 143 1696 1697 I-contraception_consent
abstinence 144 154 1698 1708 I-contraception_consent
) 154 155 1708 1709 I-contraception_consent
prior 156 161 1710 1715 O
to 162 164 1716 1718 O
study 165 170 1719 1724 O
entry 171 176 1725 1730 O
and 177 180 1731 1734 O
for 181 184 1735 1738 O
4 185 186 1739 1740 B-upper_bound
months 187 193 1741 1747 I-upper_bound
after 194 199 1748 1753 I-upper_bound
the 200 203 1754 1757 O
last 204 208 1758 1762 O
dose 209 213 1763 1767 O
of 214 216 1768 1770 O
study 217 222 1771 1776 B-treatment
drug 223 227 1777 1781 I-treatment
, 227 228 1781 1782 O
even 229 233 1783 1787 O
if 234 236 1788 1790 O
oral 237 241 1791 1795 O
contraceptives 242 256 1796 1810 O
are 257 260 1811 1814 O
used 261 265 1815 1819 O

Gastrointestinal 0 16 1820 1836 B-chronic_disease
disorders 17 26 1837 1846 I-chronic_disease
particularly 27 39 1847 1859 O
those 40 45 1860 1865 O
associated 46 56 1866 1876 O
with 57 61 1877 1881 O
a 62 63 1882 1883 O
high 64 68 1884 1888 O
risk 69 73 1889 1893 O
of 74 76 1894 1896 O
perforation 77 88 1897 1908 B-chronic_disease
or 89 91 1909 1911 O
fistula 92 99 1912 1919 B-chronic_disease
formation 100 109 1920 1929 I-chronic_disease

Gastrointestinal 0 16 1930 1946 B-chronic_disease
perforation 17 28 1947 1958 I-chronic_disease

Hemoglobin 0 10 1959 1969 B-clinical_variable
≥9 11 13 1970 1972 O
g 14 15 1973 1974 I-lower_bound
/ 15 16 1974 1975 I-lower_bound
dL 16 18 1975 1977 I-lower_bound

History 0 7 1978 1985 O
of 8 10 1986 1988 O
organ 11 16 1989 1994 B-treatment
transplant 17 27 1995 2005 I-treatment

History 0 7 2006 2013 O
of 8 10 2014 2016 O
surgery 11 18 2017 2024 B-treatment

Inflammatory 0 12 2025 2037 B-chronic_disease
bowel 13 18 2038 2043 I-chronic_disease
disease 19 26 2044 2051 I-chronic_disease
( 27 28 2052 2053 O
including 28 37 2053 2062 O
ulcerative 38 48 2063 2073 B-chronic_disease
colitis 49 56 2074 2081 I-chronic_disease
and 57 60 2082 2085 O
Crohn 61 66 2086 2091 B-chronic_disease
's 66 68 2091 2093 I-chronic_disease
disease 69 76 2094 2101 I-chronic_disease
) 76 77 2101 2102 O
, 77 78 2102 2103 O
diverticulitis 79 93 2104 2118 B-chronic_disease
, 93 94 2118 2119 O
cholecystitis 95 108 2120 2133 B-chronic_disease
, 108 109 2133 2134 O
symptomatic 110 121 2135 2146 O
cholangitis 122 133 2147 2158 B-chronic_disease
or 134 136 2159 2161 O
appendicitis 137 149 2162 2174 B-chronic_disease

Intra 0 5 2175 2180 B-chronic_disease
- 5 6 2180 2181 I-chronic_disease
abdominal 6 15 2181 2190 I-chronic_disease
abscess 16 23 2191 2198 I-chronic_disease

Intra 0 5 2199 2204 O
- 5 6 2204 2205 O
abdominal 6 15 2205 2214 O
tumor 16 21 2215 2220 B-cancer
/ 21 22 2220 2221 O
metastases 22 32 2221 2231 B-cancer
invading 33 41 2232 2240 O
GI 42 44 2241 2243 O
mucosa 45 51 2244 2250 O

Karnofsky 0 9 2251 2260 B-clinical_variable
≥60 10 13 2261 2264 O
% 13 14 2264 2265 I-lower_bound

Lipase 0 6 2266 2272 B-clinical_variable
( 7 8 2273 2274 O
no 8 10 2274 2276 O
radiologic 11 21 2277 2287 O
or 22 24 2288 2290 O
clinical 25 33 2291 2299 O
evidence 34 42 2300 2308 O
of 43 45 2309 2311 O
pancreatitis 46 58 2312 2324 B-chronic_disease
) 58 59 2324 2325 O
< 60 61 2326 2327 O
2.0 62 65 2328 2331 B-upper_bound
x 66 67 2332 2333 I-upper_bound
ULN 68 71 2334 2337 I-upper_bound

Malabsorption 0 13 2338 2351 B-chronic_disease
syndrome 14 22 2352 2360 I-chronic_disease

Male 0 4 2361 2365 B-gender
: 4 5 2365 2366 O
CrCl 6 10 2367 2371 O
( 11 12 2372 2373 O
mL 12 14 2373 2375 O
/ 14 15 2375 2376 O
min 15 18 2376 2379 O
) 18 19 2379 2380 O
= 20 21 2381 2382 O
( 22 23 2383 2384 O
140 23 26 2384 2387 O
- 27 28 2388 2389 O
age 29 32 2390 2393 B-age
) 32 33 2393 2394 O
× 34 35 2395 2396 O
wt 36 38 2397 2399 B-clinical_variable
( 39 40 2400 2401 O
kg 40 42 2401 2403 O
) 42 43 2403 2404 O
/ 44 45 2405 2406 O
( 46 47 2407 2408 O
serum 47 52 2408 2413 O
creatinine 53 63 2414 2424 O
× 64 65 2425 2426 O
72 66 68 2427 2429 O
) 68 69 2429 2430 O

Other 0 5 2431 2436 O
disorders 6 15 2437 2446 B-chronic_disease
associated 16 26 2447 2457 O
with 27 31 2458 2462 O
a 32 33 2463 2464 O
high 34 38 2465 2469 O
risk 39 43 2470 2474 O
of 44 46 2475 2477 O
fistula 47 54 2478 2485 O
formation 55 64 2486 2495 O
including 65 74 2496 2505 O
Percutaneous 75 87 2506 2518 B-treatment
Endoscopic 88 98 2519 2529 I-treatment
Gastrostomy 99 110 2530 2541 I-treatment
( 111 112 2542 2543 I-treatment
PEG 112 115 2543 2546 I-treatment
) 115 116 2546 2547 I-treatment
tube 117 121 2548 2552 I-treatment
placement 122 131 2553 2562 I-treatment
within 132 138 2563 2569 O
3 139 140 2570 2571 B-upper_bound
months 141 147 2572 2578 I-upper_bound
before 148 154 2579 2585 I-upper_bound
the 155 158 2586 2589 O
first 159 164 2590 2595 O
dose 165 169 2596 2600 O
of 170 172 2601 2603 O
study 173 178 2604 2609 B-treatment
therapy 179 186 2610 2617 I-treatment

Other 0 5 2618 2623 O
enzyme 6 12 2624 2630 O
inducing 13 21 2631 2639 O
agents 22 28 2640 2646 O
prohibited 29 39 2647 2657 O
within 40 46 2658 2664 O
2 47 48 2665 2666 B-upper_bound
weeks 49 54 2667 2672 I-upper_bound
before 55 61 2673 2679 I-upper_bound
the 62 65 2680 2683 O
first 66 71 2684 2689 O
dose 72 76 2690 2694 O
of 77 79 2695 2697 O
cabozantinib 80 92 2698 2710 B-treatment
include 93 100 2711 2718 O
rifampin 101 109 2719 2727 B-treatment
, 109 110 2727 2728 O
rifabutin 111 120 2729 2738 B-treatment
, 120 121 2738 2739 O
rifapentin 122 132 2740 2750 B-treatment
, 132 133 2750 2751 O
and 134 137 2752 2755 O
St. 138 141 2756 2759 B-treatment
John 142 146 2760 2764 I-treatment
's 146 148 2764 2766 I-treatment
Wort 149 153 2767 2771 I-treatment

Other 0 5 2772 2777 O
minor 6 11 2778 2783 B-treatment
surgery 12 19 2784 2791 I-treatment
within 20 26 2792 2798 O
28 27 29 2799 2801 B-upper_bound
days 30 34 2802 2806 I-upper_bound
of 35 37 2807 2809 O
the 38 41 2810 2813 O
first 42 47 2814 2819 O
dose 48 52 2820 2824 O
of 53 55 2825 2827 O
cabozantinib 56 68 2828 2840 B-treatment
if 69 71 2841 2843 O
there 72 77 2844 2849 O
were 78 82 2850 2854 O
no 83 85 2855 2857 O
wound 86 91 2858 2863 O
healing 92 99 2864 2871 O
complications 100 113 2872 2885 O

Patients 0 8 2886 2894 O
must 9 13 2895 2899 O
have 14 18 2900 2904 O
normal 19 25 2905 2911 O
organ 26 31 2912 2917 O
and 32 35 2918 2921 O
marrow 36 42 2922 2928 O
function 43 51 2929 2937 O
as 52 54 2938 2940 O
defined 55 62 2941 2948 O
below 63 68 2949 2954 O
: 68 69 2954 2955 O
( 70 71 2956 2957 O
within 71 77 2957 2963 O
4 78 79 2964 2965 B-upper_bound
days 80 84 2966 2970 I-upper_bound
of 85 87 2971 2973 O
beginning 88 97 2974 2983 O
treatment 98 107 2984 2993 B-treatment
unless 108 114 2994 3000 O
noted 115 120 3001 3006 O
otherwise 121 130 3007 3016 O
) 130 131 3016 3017 O

Patients 0 8 3018 3026 O
must 9 13 3027 3031 O
have 14 18 3032 3036 O
received 19 27 3037 3045 O
at 28 30 3046 3048 O
least 31 36 3049 3054 O
one 37 40 3055 3058 O
regimen 41 48 3059 3066 O
for 49 52 3067 3070 O
systemic 53 61 3071 3079 B-chronic_disease
disease 62 69 3080 3087 I-chronic_disease
which 70 75 3088 3093 O
may 76 79 3094 3097 O
be 80 82 3098 3100 O
cytotoxic 83 92 3101 3110 B-treatment
or 93 95 3111 3113 O
oral 96 100 3114 3118 B-treatment
tyrosine 101 109 3119 3127 I-treatment
kinase 110 116 3128 3134 I-treatment
inhibitor 117 126 3135 3144 I-treatment
therapy 127 134 3145 3152 I-treatment

Patients 0 8 3153 3161 O
must 9 13 3162 3166 O
have 14 18 3167 3171 O
tumor 19 24 3172 3177 B-cancer
tissue 25 31 3178 3184 O
available 32 41 3185 3194 O
for 42 45 3195 3198 O
submission 46 56 3199 3209 O
that 57 61 3210 3214 O
is 62 64 3215 3217 O
sufficient 65 75 3218 3228 O
to 76 78 3229 3231 O
complete 79 87 3232 3240 O
c 88 89 3241 3242 O
- 89 90 3242 3243 O
MET 90 93 3243 3246 O
Fluorescence 94 106 3247 3259 B-treatment
in 107 109 3260 3262 I-treatment
Situ 110 114 3263 3267 I-treatment
Hybridization 115 128 3268 3281 I-treatment
( 129 130 3282 3283 I-treatment
FISH 130 134 3283 3287 I-treatment
) 134 135 3287 3288 I-treatment
studies 136 143 3289 3296 O
as 144 146 3297 3299 O
well 147 151 3300 3304 O
as 152 154 3305 3307 O
routine 155 162 3308 3315 O
molecular 163 172 3316 3325 O
profiling 173 182 3326 3335 O
at 183 185 3336 3338 O
the 186 189 3339 3342 O
UPMC 190 194 3343 3347 O

Patients 0 8 3348 3356 O
receiving 9 18 3357 3366 O
glucocorticoids 19 34 3367 3382 B-treatment
must 35 39 3383 3387 O
be 40 42 3388 3390 O
on 43 45 3391 3393 O
a 46 47 3394 3395 O
stable 48 54 3396 3402 O
dose 55 59 3403 3407 O
of 60 62 3408 3410 O
glucocorticoids 63 78 3411 3426 O
during 79 85 3427 3433 O
the 86 89 3434 3437 O
5 90 91 3438 3439 B-upper_bound
days 92 96 3440 3444 I-upper_bound
prior 97 102 3445 3450 I-upper_bound
to 103 105 3451 3453 O
the 106 109 3454 3457 O
baseline 110 118 3458 3466 O
brain 119 124 3467 3472 B-treatment
imaging 125 132 3473 3480 I-treatment

Patients 0 8 3481 3489 O
who 9 12 3490 3493 O
have 13 17 3494 3498 O
undergone 18 27 3499 3508 O
treatment 28 37 3509 3518 B-treatment
for 38 41 3519 3522 O
their 42 47 3523 3528 O
brain 48 53 3529 3534 B-treatment
metastases 54 64 3535 3545 I-treatment
with 65 69 3546 3550 O
whole 70 75 3551 3556 B-treatment
brain 76 81 3557 3562 I-treatment
radiotherapy 82 94 3563 3575 I-treatment
, 94 95 3575 3576 O
stereotactic 96 108 3577 3589 B-treatment
radiosurgery 109 121 3590 3602 I-treatment
, 121 122 3602 3603 O
or 123 125 3604 3606 O
surgical 126 134 3607 3615 B-treatment
resection 135 144 3616 3625 I-treatment
must 145 149 3626 3630 O
be 150 152 3631 3633 O
clinically 153 163 3634 3644 O
stable 164 170 3645 3651 O
and 171 174 3652 3655 O
recovered 175 184 3656 3665 O
from 185 189 3666 3670 O
all 190 193 3671 3674 O
procedures 194 204 3675 3685 O
at 205 207 3686 3688 O
the 208 211 3689 3692 O
time 212 216 3693 3697 O
of 217 219 3698 3700 O
study 220 225 3701 3706 O
enrollment 226 236 3707 3717 O

Patients 0 8 3718 3726 O
with 9 13 3727 3731 O
clinically 14 24 3732 3742 O
asymptomatic 25 37 3743 3755 O
untreated 38 47 3756 3765 O
brain 48 53 3766 3771 B-cancer
metastases 54 64 3772 3782 I-cancer
will 65 69 3783 3787 O
be 70 72 3788 3790 O
allowed 73 80 3791 3798 O
on 81 83 3799 3801 O
trial 84 89 3802 3807 O
at 90 92 3808 3810 O
the 93 96 3811 3814 O
discretion 97 107 3815 3825 O
of 108 110 3826 3828 O
the 111 114 3829 3832 O
treating 115 123 3833 3841 O
physician 124 133 3842 3851 O

Patients 0 8 3852 3860 O
' 8 9 3860 3861 O
tumors 10 16 3862 3868 B-cancer
must 17 21 3869 3873 O
undergo 22 29 3874 3881 O
testing 30 37 3882 3889 O
for 38 41 3890 3893 O
Epidermal 42 51 3894 3903 B-treatment
Growth 52 58 3904 3910 I-treatment
Factor 59 65 3911 3917 I-treatment
Receptor 66 74 3918 3926 I-treatment
( 75 76 3927 3928 I-treatment
EGFR 76 80 3928 3932 I-treatment
) 80 81 3932 3933 I-treatment
exon 82 86 3934 3938 I-treatment
19 87 89 3939 3941 I-treatment
deletion 90 98 3942 3950 I-treatment
, 98 99 3950 3951 O
EGFR 100 104 3952 3956 B-treatment
exon 105 109 3957 3961 I-treatment
21 110 112 3962 3964 I-treatment
L858R 113 118 3965 3970 I-treatment
substitution 119 131 3971 3983 I-treatment
, 131 132 3983 3984 O
and 133 136 3985 3988 O
anaplastic 137 147 3989 3999 B-treatment
lymphoma 148 156 4000 4008 I-treatment
kinase 157 163 4009 4015 I-treatment
( 164 165 4016 4017 I-treatment
ALK 165 168 4017 4020 I-treatment
) 168 169 4020 4021 I-treatment
rearrangements 170 184 4022 4036 O

Platelets 0 9 4037 4046 B-clinical_variable
≥100,000 10 18 4047 4055 O
/ 18 19 4055 4056 I-lower_bound
mm3 19 22 4056 4059 I-lower_bound

Previously 0 10 4060 4070 O
treated 11 18 4071 4078 O
patients 19 27 4079 4087 O
with 28 32 4088 4092 O
non 33 36 4093 4096 B-cancer
- 36 37 4096 4097 I-cancer
squamous 37 45 4097 4105 I-cancer
NSCLC 46 51 4106 4111 I-cancer
who 52 55 4112 4115 O
have 56 60 4116 4120 O
had 61 64 4121 4124 O
brain 65 70 4125 4130 B-cancer
metastases 71 81 4131 4141 I-cancer
at 82 84 4142 4144 O
any 85 88 4145 4148 O
point 89 94 4149 4154 O
in 95 97 4155 4157 O
their 98 103 4158 4163 O
treatment 104 113 4164 4173 B-treatment
history 114 121 4174 4181 O

Prior 0 5 4182 4187 B-treatment
treatment 6 15 4188 4197 I-treatment
with 16 20 4198 4202 I-treatment
cabozantinib 21 33 4203 4215 I-treatment
or 34 36 4216 4218 O
other 37 42 4219 4224 O
c 43 44 4225 4226 B-treatment
- 44 45 4226 4227 I-treatment
MET 45 48 4227 4230 I-treatment
directed 49 57 4231 4239 I-treatment
therapy 58 65 4240 4247 I-treatment

Serious 0 7 4248 4255 O
active 8 14 4256 4262 B-chronic_disease
infection 15 24 4263 4272 I-chronic_disease
requiring 25 34 4273 4282 O
systemic 35 43 4283 4291 B-treatment
treatment 44 53 4292 4301 I-treatment
within 54 60 4302 4308 O
28 61 63 4309 4311 B-upper_bound
days 64 68 4312 4316 I-upper_bound
before 69 75 4317 4323 O
the 76 79 4324 4327 O
first 80 85 4328 4333 O
dose 86 90 4334 4338 O
of 91 93 4339 4341 O
study 94 99 4342 4347 O
treatment 100 109 4348 4357 O

Serious 0 7 4358 4365 B-chronic_disease
non 8 11 4366 4369 I-chronic_disease
- 11 12 4369 4370 I-chronic_disease
healing 12 19 4370 4377 I-chronic_disease
wound 20 25 4378 4383 I-chronic_disease
/ 25 26 4383 4384 O
ulcer 26 31 4384 4389 B-chronic_disease
/ 31 32 4389 4390 O
bone 32 36 4390 4394 O
fracture 37 45 4395 4403 O
within 46 52 4404 4410 O
28 53 55 4411 4413 B-upper_bound
days 56 60 4414 4418 I-upper_bound
before 61 67 4419 4425 I-upper_bound
the 68 71 4426 4429 O
first 72 77 4430 4435 O
dose 78 82 4436 4440 O
of 83 85 4441 4443 O
study 86 91 4444 4449 O
treatment 92 101 4450 4459 B-treatment

Serum 0 5 4460 4465 B-clinical_variable
creatinine 6 16 4466 4476 I-clinical_variable
≤ 17 18 4477 4478 O
1.5 19 22 4479 4482 B-upper_bound
x 23 24 4483 4484 I-upper_bound
ULN 25 28 4485 4488 I-upper_bound

Serum 0 5 4489 4494 B-clinical_variable
phosphorus 6 16 4495 4505 I-clinical_variable
, 16 17 4505 4506 O
calcium 18 25 4507 4514 B-clinical_variable
, 25 26 4514 4515 O
magnesium 27 36 4516 4525 B-clinical_variable
and 37 40 4526 4529 O
potassium 41 50 4530 4539 B-clinical_variable
≥ 51 52 4540 4541 O
LLN 53 56 4542 4545 O

Subjects 0 8 4546 4554 O
with 9 13 4555 4559 O
a 14 15 4560 4561 O
history 16 23 4562 4569 O
of 24 26 4570 4572 O
early 27 32 4573 4578 O
stage 33 38 4579 4584 O
or 39 41 4585 4587 O
locally 42 49 4588 4595 O
advanced 50 58 4596 4604 O
non 59 62 4605 4608 B-cancer
- 62 63 4608 4609 I-cancer
metastatic 63 73 4609 4619 I-cancer
prostate 74 82 4620 4628 I-cancer
cancer 83 89 4629 4635 I-cancer
within 90 96 4636 4642 O
2 97 98 4643 4644 B-upper_bound
years 99 104 4645 4650 I-upper_bound
of 105 107 4651 4653 O
the 108 111 4654 4657 O
start 112 117 4658 4663 O
of 118 120 4664 4666 O
study 121 126 4667 4672 O
treatment 127 136 4673 4682 B-treatment
may 137 140 4683 4686 O
be 141 143 4687 4689 O
included 144 152 4690 4698 O
in 153 155 4699 4701 O
the 156 159 4702 4705 O
study 160 165 4706 4711 O

The 0 3 4712 4715 O
subject 4 11 4716 4723 O
has 12 15 4724 4727 O
a 16 17 4728 4729 O
corrected 18 27 4730 4739 O
QT 28 30 4740 4742 B-clinical_variable
interval 31 39 4743 4751 I-clinical_variable
calculated 40 50 4752 4762 I-clinical_variable
by 51 53 4763 4765 I-clinical_variable
the 54 57 4766 4769 I-clinical_variable
Fridericia 58 68 4770 4780 I-clinical_variable
formula 69 76 4781 4788 I-clinical_variable
( 77 78 4789 4790 I-clinical_variable
QTcF 78 82 4790 4794 I-clinical_variable
) 82 83 4794 4795 I-clinical_variable
> 84 85 4796 4797 O
500 85 88 4797 4800 B-lower_bound
ms 89 91 4801 4803 I-lower_bound
within 92 98 4804 4810 O
28 99 101 4811 4813 B-upper_bound
days 102 106 4814 4818 I-upper_bound
before 107 113 4819 4825 I-upper_bound
randomization 114 127 4826 4839 O

The 0 3 4840 4843 O
subject 4 11 4844 4851 O
has 12 15 4852 4855 O
a 16 17 4856 4857 O
previously 18 28 4858 4868 O
identified 29 39 4869 4879 O
allergy 40 47 4880 4887 O
or 48 50 4888 4890 O
hypersensitivity 51 67 4891 4907 O
to 68 70 4908 4910 O
components 71 81 4911 4921 B-allergy_name
of 82 84 4922 4924 I-allergy_name
the 85 88 4925 4928 I-allergy_name
study 89 94 4929 4934 I-allergy_name
treatment 95 104 4935 4944 I-allergy_name
formulation 105 116 4945 4956 I-allergy_name

The 0 3 4957 4960 O
subject 4 11 4961 4968 O
has 12 15 4969 4972 O
evidence 16 24 4973 4981 O
of 25 27 4982 4984 O
acute 28 33 4985 4990 O
intracranial 34 46 4991 5003 B-chronic_disease
or 47 49 5004 5006 I-chronic_disease
intratumoral 50 62 5007 5019 I-chronic_disease
hemorrhage 63 73 5020 5030 I-chronic_disease
either 74 80 5031 5037 O
by 81 83 5038 5040 O
MRI 84 87 5041 5044 B-treatment
or 88 90 5045 5047 O
computerized 91 103 5048 5060 B-treatment
tomography 104 114 5061 5071 I-treatment
( 115 116 5072 5073 I-treatment
CT 116 118 5073 5075 I-treatment
) 118 119 5075 5076 I-treatment
scan 120 124 5077 5081 I-treatment

The 0 3 5082 5085 O
subject 4 11 5086 5093 O
has 12 15 5094 5097 O
evidence 16 24 5098 5106 O
of 25 27 5107 5109 O
tumor 28 33 5110 5115 B-cancer
invading 34 42 5116 5124 O
the 43 46 5125 5128 O
Gastro 47 53 5129 5135 O
Intestinal 54 64 5136 5146 O
( 65 66 5147 5148 O
GI 66 68 5148 5150 O
) 68 69 5150 5151 O
tract 70 75 5152 5157 O
( 76 77 5158 5159 O
esophagus 77 86 5159 5168 O
, 86 87 5168 5169 O
stomach 88 95 5170 5177 O
, 95 96 5177 5178 O
small 97 102 5179 5184 O
or 103 105 5185 5187 O
large 106 111 5188 5193 O
bowel 112 117 5194 5199 O
, 117 118 5199 5200 O
rectum 119 125 5201 5207 O
or 126 128 5208 5210 O
anus 129 133 5211 5215 O
) 133 134 5215 5216 O
, 134 135 5216 5217 O
or 136 138 5218 5220 O
any 139 142 5221 5224 O
evidence 143 151 5225 5233 O
of 152 154 5234 5236 O
endotracheal 155 167 5237 5249 B-cancer
or 168 170 5250 5252 O
endobronchial 171 184 5253 5266 B-cancer
tumor 185 190 5267 5272 I-cancer
within 191 197 5273 5279 O
28 198 200 5280 5282 B-upper_bound
days 201 205 5283 5287 I-upper_bound
before 206 212 5288 5294 I-upper_bound
the 213 216 5295 5298 O
first 217 222 5299 5304 O
dose 223 227 5305 5309 O
of 228 230 5310 5312 O
cabozantinib 231 243 5313 5325 B-treatment

The 0 3 5326 5329 O
subject 4 11 5330 5337 O
has 12 15 5338 5341 O
had 16 19 5342 5345 O
an 20 22 5346 5348 O
assessment 23 33 5349 5359 O
of 34 36 5360 5362 O
all 37 40 5363 5366 O
extracranial 41 53 5367 5379 B-chronic_disease
disease 54 61 5380 5387 I-chronic_disease
sites 62 67 5388 5393 O
( 68 69 5394 5395 O
e.g. 69 73 5395 5399 O
, 73 74 5399 5400 O
by 75 77 5401 5403 O
computerized 78 90 5404 5416 B-treatment
tomography 91 101 5417 5427 I-treatment
( 102 103 5428 5429 I-treatment
CT 103 105 5429 5431 I-treatment
) 105 106 5431 5432 I-treatment
scan 107 111 5433 5437 I-treatment
, 111 112 5437 5438 O
positron 113 121 5439 5447 B-treatment
emission 122 130 5448 5456 I-treatment
tomography 131 141 5457 5467 I-treatment
- 141 142 5467 5468 I-treatment
CT 142 144 5468 5470 I-treatment
, 144 145 5470 5471 O
and 146 149 5472 5475 O
bone 150 154 5476 5480 B-treatment
scan 155 159 5481 5485 I-treatment
as 160 162 5486 5488 O
appropriate 163 174 5489 5500 O
) 174 175 5500 5501 O
within 176 182 5502 5508 O
28 183 185 5509 5511 B-upper_bound
days 186 190 5512 5516 I-upper_bound
before 191 197 5517 5523 I-upper_bound
the 198 201 5524 5527 O
first 202 207 5528 5533 O
dose 208 212 5534 5538 O
of 213 215 5539 5541 O
cabozantinib 216 228 5542 5554 B-treatment

The 0 3 5555 5558 O
subject 4 11 5559 5566 O
has 12 15 5567 5570 O
had 16 19 5571 5574 O
evidence 20 28 5575 5583 O
within 29 35 5584 5590 O
2 36 37 5591 5592 B-upper_bound
years 38 43 5593 5598 I-upper_bound
of 44 46 5599 5601 O
the 47 50 5602 5605 O
start 51 56 5606 5611 O
of 57 59 5612 5614 O
study 60 65 5615 5620 O
treatment 66 75 5621 5630 B-treatment
of 76 78 5631 5633 O
another 79 86 5634 5641 O
malignancy 87 97 5642 5652 B-cancer
which 98 103 5653 5658 O
required 104 112 5659 5667 O
systemic 113 121 5668 5676 B-treatment
treatment 122 131 5677 5686 I-treatment

The 0 3 5687 5690 O
subject 4 11 5691 5698 O
has 12 15 5699 5702 O
not 16 19 5703 5706 O
recovered 20 29 5707 5716 O
to 30 32 5717 5719 O
baseline 33 41 5720 5728 O
or 42 44 5729 5731 O
CTCAE 45 50 5732 5737 B-clinical_variable
≤ 51 52 5738 5739 O
Grade 53 58 5740 5745 B-upper_bound
1 59 60 5746 5747 I-upper_bound
from 61 65 5748 5752 O
toxicity 66 74 5753 5761 O
due 75 78 5762 5765 O
to 79 81 5766 5768 O
all 82 85 5769 5772 O
prior 86 91 5773 5778 B-treatment
therapies 92 101 5779 5788 I-treatment

The 0 3 5789 5792 O
subject 4 11 5793 5800 O
has 12 15 5801 5804 O
prothrombin 16 27 5805 5816 B-clinical_variable
time 28 32 5817 5821 I-clinical_variable
( 33 34 5822 5823 I-clinical_variable
PT)/ 34 38 5823 5827 I-clinical_variable
International 39 52 5828 5841 B-clinical_variable
Normalized 53 63 5842 5852 I-clinical_variable
Ratio 64 69 5853 5858 I-clinical_variable
( 70 71 5859 5860 I-clinical_variable
INR 71 74 5860 5863 I-clinical_variable
) 74 75 5863 5864 I-clinical_variable
or 76 78 5865 5867 I-clinical_variable
partial 79 86 5868 5875 I-clinical_variable
thromboplastin 87 101 5876 5890 I-clinical_variable
time 102 106 5891 5895 I-clinical_variable
( 107 108 5896 5897 I-clinical_variable
PTT 108 111 5897 5900 I-clinical_variable
) 111 112 5900 5901 I-clinical_variable
test 113 117 5902 5906 O
≥ 118 119 5907 5908 O
1.3 120 123 5909 5912 B-lower_bound
x 124 125 5913 5914 I-lower_bound
the 126 129 5915 5918 I-lower_bound
laboratory 130 140 5919 5929 I-lower_bound
ULN 141 144 5930 5933 I-lower_bound
within 145 151 5934 5940 O
7 152 153 5941 5942 B-upper_bound
days 154 158 5943 5947 I-upper_bound
before 159 165 5948 5954 I-upper_bound
the 166 169 5955 5958 O
first 170 175 5959 5964 O
dose 176 180 5965 5969 O
of 181 183 5970 5972 O
study 184 189 5973 5978 O
treatment 190 199 5979 5988 B-treatment

The 0 3 5989 5992 O
subject 4 11 5993 6000 O
has 12 15 6001 6004 O
received 16 24 6005 6013 O
cytotoxic 25 34 6014 6023 B-treatment
chemotherapy 35 47 6024 6036 I-treatment
( 48 49 6037 6038 O
including 49 58 6038 6047 O
investigational 59 74 6048 6063 B-treatment
cytotoxic 75 84 6064 6073 I-treatment
chemotherapy 85 97 6074 6086 I-treatment
) 97 98 6086 6087 O
or 99 101 6088 6090 O
biologic 102 110 6091 6099 B-treatment
agents 111 117 6100 6106 I-treatment
( 118 119 6107 6108 O
e.g. 119 123 6108 6112 O
, 123 124 6112 6113 O
cytokines 125 134 6114 6123 B-treatment
or 135 137 6124 6126 O
antibodies 138 148 6127 6137 B-treatment
; 148 149 6137 6138 O
including 150 159 6139 6148 O
investigational 160 175 6149 6164 B-treatment
biologic 176 184 6165 6173 I-treatment
agents 185 191 6174 6180 I-treatment
) 191 192 6180 6181 O
within 193 199 6182 6188 O
3 200 201 6189 6190 B-upper_bound
weeks 202 207 6191 6196 I-upper_bound
, 207 208 6196 6197 O
or 209 211 6198 6200 O
nitrosoureas/ 212 225 6201 6214 B-treatment
mitomycin 226 235 6215 6224 B-treatment
C 236 237 6225 6226 I-treatment
within 238 244 6227 6233 O
6 245 246 6234 6235 B-upper_bound
weeks 247 252 6236 6241 I-upper_bound
before 253 259 6242 6248 I-upper_bound
the 260 263 6249 6252 O
first 264 269 6253 6258 O
dose 270 274 6259 6263 O
of 275 277 6264 6266 O
study 278 283 6267 6272 O
treatment 284 293 6273 6282 B-treatment

The 0 3 6283 6286 O
subject 4 11 6287 6294 O
has 12 15 6295 6298 O
received 16 24 6299 6307 B-treatment
enzyme 25 31 6308 6314 I-treatment
- 31 32 6314 6315 I-treatment
inducing 32 40 6315 6323 I-treatment
anti 41 45 6324 6328 I-treatment
- 45 46 6328 6329 I-treatment
epileptic 46 55 6329 6338 I-treatment
agents 56 62 6339 6345 I-treatment
within 63 69 6346 6352 O
2 70 71 6353 6354 B-upper_bound
weeks 72 77 6355 6360 I-upper_bound
before 78 84 6361 6367 O
the 85 88 6368 6371 O
first 89 94 6372 6377 O
dose 95 99 6378 6382 O
of 100 102 6383 6385 O
cabozantinib 103 115 6386 6398 B-treatment
( 116 117 6399 6400 O
e.g. 117 121 6400 6404 O
, 121 122 6404 6405 O
carbamazepine 123 136 6406 6419 B-treatment
, 136 137 6419 6420 O
phenytoin 138 147 6421 6430 B-treatment
, 147 148 6430 6431 O
phenobarbital 149 162 6432 6445 B-treatment
, 162 163 6445 6446 O
primidone 164 173 6447 6456 B-treatment
) 173 174 6456 6457 O

The 0 3 6458 6461 O
subject 4 11 6462 6469 O
has 12 15 6470 6473 O
received 16 24 6474 6482 O
prior 25 30 6483 6488 B-treatment
treatment 31 40 6489 6498 I-treatment
with 41 45 6499 6503 O
a 46 47 6504 6505 O
small 48 53 6506 6511 B-treatment
molecule 54 62 6512 6520 I-treatment
kinase 63 69 6521 6527 I-treatment
inhibitor 70 79 6528 6537 I-treatment
or 80 82 6538 6540 O
a 83 84 6541 6542 O
hormonal 85 93 6543 6551 B-treatment
therapy 94 101 6552 6559 I-treatment
( 102 103 6560 6561 O
including 103 112 6561 6570 O
investigational 113 128 6571 6586 B-treatment
kinase 129 135 6587 6593 I-treatment
inhibitors 136 146 6594 6604 I-treatment
or 147 149 6605 6607 I-treatment
hormones 150 158 6608 6616 I-treatment
) 158 159 6616 6617 O
within 160 166 6618 6624 O
14 167 169 6625 6627 B-upper_bound
days 170 174 6628 6632 I-upper_bound
or 175 177 6633 6635 O
five 178 182 6636 6640 O
half 183 187 6641 6645 O
- 187 188 6645 6646 O
lives 188 193 6646 6651 O
of 194 196 6652 6654 O
the 197 200 6655 6658 O
compound 201 209 6659 6667 O
or 210 212 6668 6670 O
active 213 219 6671 6677 O
metabolites 220 231 6678 6689 O
, 231 232 6689 6690 O
whichever 233 242 6691 6700 O
is 243 245 6701 6703 O
longer 246 252 6704 6710 O
, 252 253 6710 6711 O
before 254 260 6712 6718 O
the 261 264 6719 6722 O
first 265 270 6723 6728 O
dose 271 275 6729 6733 O
of 276 278 6734 6736 O
study 279 284 6737 6742 O
treatment 285 294 6743 6752 O

The 0 3 6753 6756 O
subject 4 11 6757 6764 O
has 12 15 6765 6768 O
received 16 24 6769 6777 O
radiation 25 34 6778 6787 B-treatment
therapy 35 42 6788 6795 I-treatment

The 0 3 6796 6799 O
subject 4 11 6800 6807 O
has 12 15 6808 6811 O
received 16 24 6812 6820 O
radionuclide 25 37 6821 6833 B-treatment
treatment 38 47 6834 6843 I-treatment
within 48 54 6844 6850 O
6 55 56 6851 6852 B-upper_bound
weeks 57 62 6853 6858 I-upper_bound
of 63 65 6859 6861 O
the 66 69 6862 6865 O
first 70 75 6866 6871 O
dose 76 80 6872 6876 O
of 81 83 6877 6879 O
study 84 89 6880 6885 O
treatment 90 99 6886 6895 O

The 0 3 6896 6899 O
subject 4 11 6900 6907 O
has 12 15 6908 6911 O
tumor 16 21 6912 6917 B-cancer
abutting 22 30 6918 6926 O
, 30 31 6926 6927 O
invading 32 40 6928 6936 O
or 41 43 6937 6939 O
encasing 44 52 6940 6948 O
any 53 56 6949 6952 O
major 57 62 6953 6958 O
blood 63 68 6959 6964 O
vessels 69 76 6965 6972 O

The 0 3 6973 6976 O
subject 4 11 6977 6984 O
is 12 14 6985 6987 O
receiving 15 24 6988 6997 O
concomitant 25 36 6998 7009 O
treatment 37 46 7010 7019 B-treatment
with 47 51 7020 7024 I-treatment
warfarin 52 60 7025 7033 I-treatment
, 60 61 7033 7034 O
warfarin 62 70 7035 7043 B-treatment
- 70 71 7043 7044 I-treatment
related 71 78 7044 7051 I-treatment
agents 79 85 7052 7058 I-treatment
, 85 86 7058 7059 O
or 87 89 7060 7062 O
low 90 93 7063 7066 B-treatment
molecular 94 103 7067 7076 I-treatment
weight 104 110 7077 7083 I-treatment
heparin 111 118 7084 7091 I-treatment
( 119 120 7092 7093 I-treatment
LMWH 120 124 7093 7097 I-treatment
) 124 125 7097 7098 I-treatment
at 126 128 7099 7101 O
the 129 132 7102 7105 O
time 133 137 7106 7110 O
of 138 140 7111 7113 O
study 141 146 7114 7119 O
entry 147 152 7120 7125 O
at 153 155 7126 7128 O
therapeutic 156 167 7129 7140 O
doses 168 173 7141 7146 O
. 173 174 7146 7147 O
Low 175 178 7148 7151 B-treatment
- 178 179 7151 7152 I-treatment
dose 179 183 7152 7156 I-treatment
warfarin 184 192 7157 7165 I-treatment
( 193 194 7166 7167 O
≤ 194 195 7167 7168 O
1 196 197 7169 7170 B-upper_bound
mg 198 200 7171 7173 I-upper_bound
/ 200 201 7173 7174 I-upper_bound
day 201 204 7174 7177 I-upper_bound
) 204 205 7177 7178 O
or 206 208 7179 7181 O
LMWH 209 213 7182 7186 O
at 214 216 7187 7189 O
prophylactic 217 229 7190 7202 O
doses 230 235 7203 7208 O

The 0 3 7209 7212 O
subject 4 11 7213 7220 O
must 12 16 7221 7225 O
have 17 21 7226 7230 O
a 22 23 7231 7232 O
baseline 24 32 7233 7241 O
brain 33 38 7242 7247 O
MRI 39 42 7248 7251 B-treatment
scan 43 47 7252 7256 I-treatment
or 48 50 7257 7259 O
CT 51 53 7260 7262 B-treatment
scan 54 58 7263 7267 I-treatment
of 59 61 7268 7270 I-treatment
the 62 65 7271 7274 I-treatment
head 66 70 7275 7279 I-treatment
( 71 72 7280 7281 O
in 72 74 7281 7283 O
patients 75 83 7284 7292 O
unable 84 90 7293 7299 O
to 91 93 7300 7302 O
obtain 94 100 7303 7309 O
an 101 103 7310 7312 O
MRI 104 107 7313 7316 O
) 107 108 7316 7317 O
within 109 115 7318 7324 O
14 116 118 7325 7327 B-upper_bound
days 119 123 7328 7332 I-upper_bound
prior 124 129 7333 7338 I-upper_bound
to 130 132 7339 7341 O
first 133 138 7342 7347 O
dose 139 143 7348 7352 O
of 144 146 7353 7355 O
cabozantinib 147 159 7356 7368 B-treatment

To 0 2 7369 7371 O
any 3 6 7372 7375 O
other 7 12 7376 7381 O
site(s 13 19 7382 7388 O
) 19 20 7388 7389 O
within 21 27 7390 7396 O
28 28 30 7397 7399 B-upper_bound
days 31 35 7400 7404 I-upper_bound
of 36 38 7405 7407 O
the 39 42 7408 7411 O
first 43 48 7412 7417 O
dose 49 53 7418 7422 O
of 54 56 7423 7425 O
study 57 62 7426 7431 B-treatment
treatment 63 72 7432 7441 I-treatment

To 0 2 7442 7444 O
bone 3 7 7445 7449 B-cancer
or 8 10 7450 7452 O
brain 11 16 7453 7458 B-cancer
metastasis 17 27 7459 7469 I-cancer
within 28 34 7470 7476 O
14 35 37 7477 7479 B-upper_bound
days 38 42 7480 7484 I-upper_bound
of 43 45 7485 7487 O
the 46 49 7488 7491 O
first 50 55 7492 7497 O
dose 56 60 7498 7502 O
of 61 63 7503 7505 O
study 64 69 7506 7511 O
treatment 70 79 7512 7521 B-treatment

To 0 2 7522 7524 O
the 3 6 7525 7528 O
thoracic 7 15 7529 7537 O
cavity 16 22 7538 7544 O
, 22 23 7544 7545 O
abdomen 24 31 7546 7553 O
or 32 34 7554 7556 O
pelvis 35 41 7557 7563 O
within 42 48 7564 7570 O
3 49 50 7571 7572 B-upper_bound
months 51 57 7573 7579 I-upper_bound
of 58 60 7580 7582 O
the 61 64 7583 7586 O
first 65 70 7587 7592 O
dose 71 75 7593 7597 O
of 76 78 7598 7600 O
study 79 84 7601 7606 O
treatment 85 94 7607 7616 B-treatment
or 95 97 7617 7619 O
has 98 101 7620 7623 O
with 102 106 7624 7628 O
ongoing 107 114 7629 7636 O
complications 115 128 7637 7650 O
or 129 131 7651 7653 O
is 132 134 7654 7656 O
without 135 142 7657 7664 O
complete 143 151 7665 7673 O
recovery 152 160 7674 7682 O
and 161 164 7683 7686 O
healing 165 172 7687 7694 O
from 173 177 7695 7699 O
prior 178 183 7700 7705 B-treatment
radiation 184 193 7706 7715 I-treatment
therapy 194 201 7716 7723 I-treatment

Urine 0 5 7724 7729 B-clinical_variable
protein 6 13 7730 7737 I-clinical_variable
/ 13 14 7737 7738 I-clinical_variable
creatinine 14 24 7738 7748 I-clinical_variable
ratio 25 30 7749 7754 I-clinical_variable
( 31 32 7755 7756 I-clinical_variable
UPCR 32 36 7756 7760 I-clinical_variable
) 36 37 7760 7761 I-clinical_variable
≤1 38 40 7762 7764 O

Women 0 5 7765 7770 B-gender
of 6 8 7771 7773 O
childbearing 9 21 7774 7786 O
potential 22 31 7787 7796 O
must 32 36 7797 7801 O
have 37 41 7802 7806 O
a 42 43 7807 7808 O
negative 44 52 7809 7817 B-pregnancy
serum 53 58 7818 7823 I-pregnancy
pregnancy 59 68 7824 7833 I-pregnancy
test 69 73 7834 7838 O
at 74 76 7839 7841 O
screening 77 86 7842 7851 O

c 0 1 7852 7853 O
- 1 2 7853 7854 O
MET 2 5 7854 7857 O
amplification 6 19 7858 7871 O
will 20 24 7872 7876 O
be 25 27 7877 7879 O
determined 28 38 7880 7890 O
by 39 41 7891 7893 O
FISH 42 46 7894 7898 B-treatment
ratio 47 52 7899 7904 O
( 53 54 7905 7906 O
c 54 55 7906 7907 B-clinical_variable
- 55 56 7907 7908 I-clinical_variable
MET 56 59 7908 7911 I-clinical_variable
/ 59 60 7911 7912 I-clinical_variable
CEP7 60 64 7912 7916 I-clinical_variable
) 64 65 7916 7917 O
> 66 67 7918 7919 O
2.0 68 71 7920 7923 B-lower_bound
, 71 72 7923 7924 O
based 73 78 7925 7930 O
on 79 81 7931 7933 O
testing 82 89 7934 7941 O
of 90 92 7942 7944 O
the 93 96 7945 7948 O
primary 97 104 7949 7956 O
tumor 105 110 7957 7962 B-cancer
and/or 111 117 7963 7969 O
site 118 122 7970 7974 O
of 123 125 7975 7977 O
metastatic 126 136 7978 7988 B-cancer
disease 137 144 7989 7996 I-cancer

clinically 0 10 7997 8007 O
- 10 11 8007 8008 O
significant 11 22 8008 8019 O
cardiac 23 30 8020 8027 O
arrhythmias 31 42 8028 8039 B-chronic_disease

myocardial 0 10 8040 8050 B-chronic_disease
infarction 11 21 8051 8061 I-chronic_disease
( 22 23 8062 8063 I-chronic_disease
MI 23 25 8063 8065 I-chronic_disease
) 25 26 8065 8066 I-chronic_disease

pregnant 0 8 8067 8075 B-pregnancy

stroke 0 6 8076 8082 B-chronic_disease
( 7 8 8083 8084 O
including 8 17 8084 8093 O
Transient 18 27 8094 8103 B-chronic_disease
Ischemic 28 36 8104 8112 I-chronic_disease
Attack 37 43 8113 8119 I-chronic_disease
( 44 45 8120 8121 I-chronic_disease
TIA 45 48 8121 8124 I-chronic_disease
) 48 49 8124 8125 I-chronic_disease
, 49 50 8125 8126 O
or 51 53 8127 8129 O
other 54 59 8130 8135 O
ischemic 60 68 8136 8144 O
event 69 74 8145 8150 O

thromboembolic 0 14 8151 8165 B-chronic_disease
event 15 20 8166 8171 O
requiring 21 30 8172 8181 O
therapeutic 31 42 8182 8193 B-treatment
anticoagulation 43 58 8194 8209 I-treatment

unstable 0 8 8210 8218 O
angina 9 15 8219 8225 B-chronic_disease
pectoris 16 24 8226 8234 I-chronic_disease

